BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 11057842)

  • 1. Topical fluoroquinolones for eye and ear.
    Morden NE; Berke EM
    Am Fam Physician; 2000 Oct; 62(8):1870-6. PubMed ID: 11057842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature.
    Wall GM; Stroman DW; Roland PS; Dohar J
    Pediatr Infect Dis J; 2009 Feb; 28(2):141-4. PubMed ID: 19116600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapy for bacterial keratitis and bacterial conjunctivitis.
    Steinert RF
    Am J Ophthalmol; 1991 Oct; 112(4 Suppl):10S-14S. PubMed ID: 1928267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Otorhinolaryngology--4: Pro and contra of ear drops].
    Reiss G; Reiss M
    Pflege Z; 2002 Feb; 55(2):86-8. PubMed ID: 12640995
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical therapy of otitis externa and otitis media.
    Morris DO
    Vet Clin North Am Small Anim Pract; 2004 Mar; 34(2):541-55, vii-viii. PubMed ID: 15062623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of plasma ciprofloxacin levels in children treated with 0.2% topical ciprofloxacin for tympanic perforation].
    Clarós P; Sabater F; Clarós A; Clarós A
    Acta Otorrinolaringol Esp; 2000 Mar; 51(2):97-9. PubMed ID: 10804109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of aminoglycoside versus fluoroquinolone topical antibiotic drops.
    Manolidis S; Friedman R; Hannley M; Roland PS; Matz G; Rybak L; Stewart MG; Weber P; Owens F
    Otolaryngol Head Neck Surg; 2004 Mar; 130(3 Suppl):S83-8. PubMed ID: 15054366
    [No Abstract]   [Full Text] [Related]  

  • 8. Ofloxacin otic solution: a review of its use in the management of ear infections.
    Simpson KL; Markham A
    Drugs; 1999 Sep; 58(3):509-31. PubMed ID: 10493278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
    Al-Shawwa BA; Wegner D
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ototopical agents in the treatment of the draining ear.
    Denneny JC
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S353-60. PubMed ID: 12408221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of sparfloxacin eye drop in the management of conjunctival and corneal infection.
    Vyas U; Desai T; Shah C
    J Indian Med Assoc; 2002 Jun; 100(6):398-9. PubMed ID: 12416674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
    Rahman A; Rizwan S; Waycaster C; Wall GM
    Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Otic topical agents.
    Fairbanks DN
    Ear Nose Throat J; 1981 May; 60(5):239-42. PubMed ID: 7227274
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies for decreasing multidrug antibiotic resistance: role of ototopical agents for treatment of middle ear infections.
    Klein JO
    Am J Manag Care; 2002 Oct; 8(14 Suppl):S345-52. PubMed ID: 12408220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical treatment for otorrhea: issues and controversies.
    Bance M; Rutka JA
    J Otolaryngol; 2005 Aug; 34 Suppl 2():S52-5. PubMed ID: 16076416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [How and when is topical treatment applied into the ear?].
    Hopsu E; Närkiö-Mäkelä M; Silvola J
    Duodecim; 2011; 127(14):1470-80. PubMed ID: 21888048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic therapy for ocular infection.
    Snyder RW; Glasser DB
    West J Med; 1994 Dec; 161(6):579-84. PubMed ID: 7856158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis.
    Ghelardi E; Tavanti A; Davini P; Celandroni F; Salvetti S; Parisio E; Boldrini E; Senesi S; Campa M
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3396-401. PubMed ID: 15328102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
    Leibovitz E
    Paediatr Drugs; 2003; 5 Suppl 1():1-12. PubMed ID: 14632101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa.
    Schwartz RH
    Curr Med Res Opin; 2006 Sep; 22(9):1725-36. PubMed ID: 16968576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.